Login Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

  • Watchlist

    Keep track of companies that you follow and research.

  • 10 Years of Data

    Full access to our data with predictions and indicators that we calculate daily.

  • Screener

    Full access to our screener with tons of custom values and customizable email notifications.

  • XLS Exports

    Excel export of financials and screeners you define and save.

Subscribe now
Screener Weekly Summary

Cullinan Therapeutics, Inc. CGEM

Healthcare  —  Biotechnology
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

Register an account and get your Powerpack now or Login

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '17
Net Income (219.88) (167.57) (155.10) 109.20 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Depreciation & Amortization 0.31 0.31 0.31 0.09 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Non Cash Items (Other) 29.73 22.36 20.86 (247.13) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Accounts Payable Change (0.84) (0.81) (0.17) (0.51) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Change in payables and accrued liability 8.03 2.90 10.05 8.53 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Income tax paid — — (4.28) 4.28 ‡‡‡ — — —
Change in other assets and liabilities 6.90 (2.47) (5.94) (1.13) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Other operating activities — — — — — — — ‡‡‡
Operating Cash Flow (175.75) (145.30) (134.27) (126.66) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Capital expenditures (0.05) — (0.21) (1.04) — ‡‡‡‡‡ ‡‡‡‡‡ —
Net Aquisitions — — — 275.00 — ‡‡‡‡‡ — —
Long-Term Investments Change (Net) 180.04 (136.31) 36.01 (24.98) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Investing cash flow 179.99 (136.31) 35.81 248.98 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Repayment/Issuance of Debt (Net) — — 1.83 0.18 — — — —
Equity Repurchase (Common, Net) 1.09 270.64 38.93 6.02 ‡‡‡‡‡ ‡‡‡‡‡ — —
Equity Repurchase (Preffered, Net) — — — — — ‡‡‡‡‡ ‡‡‡‡‡ —
Other financial activities — (4.45) — (32.13) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Financing cash flow 1.09 266.19 40.75 (25.93) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Change in Cash 5.33 (15.43) (57.72) 96.38 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Beginning Cash 83.01 98.43 156.15 59.77 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Ending Cash 88.33 83.01 98.43 156.15 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Stock Based Compensation 36.04 37.82 30.44 27.96 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Dividends Paid (Common) 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
Net Cash/Marketcap — — — — ‡‡‡‡‡ — — —
Assets Liabilities Change (Total) 14.08 (0.39) (0.34) 11.18 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Investments Change (Net) 180.04 (136.31) 36.01 (24.98) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Issuance/Purchase of Shares 1.09 270.64 38.93 6.02 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Revenue per Employee 0.00 0.00 0.00 0.00 ‡‡‡‡‡ ‡‡‡ ‡‡‡ —
In millions of $ except per-share values · columns are period end dates